The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A systematic review and meta‐analysis

Published:2020-09-18 Issue:5 Volume:94 Page:731-742
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Chen Bojie¹^ORCID,Shi Yuan¹,Xu Yanan¹,Zhang Jing²

Affiliation:

1. Department of Head and Neck Surgery School of Medicine Renji Hospital Shanghai Jiao Tong University Shanghai China

2. School of Public Health Shanghai Jiao Tong University Shanghai China

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14316

Reference41 articles.

1. BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

2. BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence

3. Telomerase reverse transcriptase promoter mutation and its clinical implication in thyroid cancer;Chung JH;Precision Future Med,2018

4. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

5. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TERT promoter mutations and additional molecular alterations in thyroid fine-needle aspiration specimens: A multi-institutional study with histopathologic follow-up;American Journal of Clinical Pathology;2024-09-09

2. The value of preoperative molecular testing in the management of Bethesda V and Bethesda VI thyroid tumors;Hormones;2024-09-03

3. Modified TI-RADS Coupled with BRAFV600E Enhances Diagnostic Efficiency in Papillary Thyroid Carcinoma: Prospective Study;International Journal of General Medicine;2024-07

4. Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma;Anticancer Research;2024-06-26

5. Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules 2024;International Journal of Thyroidology;2024-05-30